Travel Notice

I wanted to let everyone know that over the next two weeks my posts might become few and far between. Iaa am traveling with my family in Alaska where my ability to find either internet or cell connections has become difficult. I will attempt to find an occasional connection and put something up. I will [...]

By |2012-08-20T02:06:49-04:00August 20th, 2012|Advanced Prostate Cancer, Uncategorized|1 Comment

Four New Sites Added to the MDV3100 (Enzalutamide) Early Access Trial

The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced [...]

All about the PSA

Over the past few months hospital support for community screening events has markedly deteriorated. The harsh truth of the overtreatment epidemic brought about through the indiscriminate application of mass screening can no longer be ignored, leaving the only reasoning for support of such events (outside of a research setting) being marketing for urology practices. BTW [...]

By |2017-10-19T10:50:57-04:00August 19th, 2012|Activism|0 Comments

So, You Think You Are Safe in Your Doctor’s Office?

When the press discusses medical mistakes they are usually referring to mistakes made in a hospital, but guess what, mistakes are often made in a doctors office. These mistakes are not counted in the statistics often quoted. Twelve year old data from the Institute of Medicine sites the horrific statistic that each year between 44,000 [...]

The Debate Continues, Is IAD or CAD Superior for the Treatment of Men with Castrate Resistant Prostate Cancer?

A new randomized study (FinnProstate Study VII) on the merits of intermittent androgen deprivation (IAD) compared to continuous androgen therapy (CAD) contradicts the recent revelations from the last ASCO presentation (Hussain et.al) where the clear conclusion was that CAD was superior to IAD. At the ASCO conference Dr. Hussain’s study concluded that IAD was significantly [...]

Go to Top